Correlation Between Iterum Therapeutics and Emergent Biosolutions
Can any of the company-specific risk be diversified away by investing in both Iterum Therapeutics and Emergent Biosolutions at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iterum Therapeutics and Emergent Biosolutions into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iterum Therapeutics PLC and Emergent Biosolutions, you can compare the effects of market volatilities on Iterum Therapeutics and Emergent Biosolutions and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iterum Therapeutics with a short position of Emergent Biosolutions. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iterum Therapeutics and Emergent Biosolutions.
Diversification Opportunities for Iterum Therapeutics and Emergent Biosolutions
0.5 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Iterum and Emergent is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Iterum Therapeutics PLC and Emergent Biosolutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emergent Biosolutions and Iterum Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iterum Therapeutics PLC are associated (or correlated) with Emergent Biosolutions. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emergent Biosolutions has no effect on the direction of Iterum Therapeutics i.e., Iterum Therapeutics and Emergent Biosolutions go up and down completely randomly.
Pair Corralation between Iterum Therapeutics and Emergent Biosolutions
Given the investment horizon of 90 days Iterum Therapeutics PLC is expected to generate 0.72 times more return on investment than Emergent Biosolutions. However, Iterum Therapeutics PLC is 1.38 times less risky than Emergent Biosolutions. It trades about -0.14 of its potential returns per unit of risk. Emergent Biosolutions is currently generating about -0.21 per unit of risk. If you would invest 180.00 in Iterum Therapeutics PLC on December 28, 2024 and sell it today you would lose (47.00) from holding Iterum Therapeutics PLC or give up 26.11% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Iterum Therapeutics PLC vs. Emergent Biosolutions
Performance |
Timeline |
Iterum Therapeutics PLC |
Emergent Biosolutions |
Iterum Therapeutics and Emergent Biosolutions Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Iterum Therapeutics and Emergent Biosolutions
The main advantage of trading using opposite Iterum Therapeutics and Emergent Biosolutions positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iterum Therapeutics position performs unexpectedly, Emergent Biosolutions can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emergent Biosolutions will offset losses from the drop in Emergent Biosolutions' long position.Iterum Therapeutics vs. Adial Pharmaceuticals | Iterum Therapeutics vs. Tonix Pharmaceuticals Holding | Iterum Therapeutics vs. Fortress Biotech | Iterum Therapeutics vs. Eyenovia |
Emergent Biosolutions vs. Zoetis Inc | Emergent Biosolutions vs. Bausch Health Companies | Emergent Biosolutions vs. Neurocrine Biosciences | Emergent Biosolutions vs. Akanda Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |